| 摘要 |
<p>The invention relates to medicine, particularly to neurology and can be used for treating ischemic brain stroke.According to the invention, the claimed method consists in that it is carried out the basic treatment, and additionally, from the 2nd day of the disease onset, is applied a suspension of autologous mononuclear cells with the concentration of 28.4×109/L and nanodiamonds of 4…10 nm in a concentration of 10-6 g/L in 0.9% saline, which is administered intravenously in 4 ml and 1 ml in the cerebrospinal fluid, once every three days, the course of treatment is 10…15 procedures.</p> |
